Nathan Cheng In his presentation entitled Longevity Startups: Past, Present, and Future at EARD 2021, Nathan S. Cheng describes how he began his own longevity startups, what the current landscape is for investors and new founders, as well as what biggest future challenges are for new longevity companies.

FOLLOW US
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]

DESCRIPTION
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Nathan S. Cheng is the program director at On Deck Longevity Biotech, the founder of Longevity Marketcap and Longevity List, a co-founder and general partner at Healthspan Capital, and the host of the Longevity Biotech Show, a growing podcast. Nathan earned his Master’s degree in Physics from the University of Toronto and was awarded both CGS-Masters and CGS-Doctoral graduate scholarships from the Natural Sciences and Engineering Research Council of Canada.


The Ending Age-Related Diseases Conference by Lifespan.io brings together leading experts in rejuvenation biotechnology to discuss new research developments, as well as investment prospects. At EARD 2021, the rejuvenation biotechnology industry was examined as an ecosystem. Gaps in coordination and collaboration were identified, as well as how those gaps could be filled by a concerted effort of the life extension community. Special attention was also paid to the burden of neurodegenerative diseases, along with innovative approaches to maintaining mental health and rejuvenating the aging brain.


HOW CAN YOU SUPPORT US?
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Lifespan.io, a 501(c)(3) nonprofit organization.
► Support us with monthly donations by becoming a Lifespan Hero: [ Ссылка ]
► Subscribe: [ Ссылка ]
► Learn more, and help us: [ Ссылка ]

#LongevityMarketcap #RejuvenationBiotechnologies #NathanCheng #EARD2021

свернуть